ACM
DRNA
AlphaCrest Capital Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-120,900
| Closed | -$2.44M | – | 1485 |
|
|
2021
Q3 | $2.44M | Buy |
+120,900
| New | +$2.44M | 0.13% | 214 |
|
|
2021
Q2 | – | Sell |
-7,900
| Closed | -$202K | – | 1392 |
|
|
2021
Q1 | $202K | Buy |
+7,900
| New | +$202K | 0.01% | 1145 |
|
|
2020
Q4 | – | Sell |
-24,100
| Closed | -$434K | – | 1318 |
|
|
2020
Q3 | $434K | Buy |
24,100
+10,600
| +79% | +$191K | 0.05% | 664 |
|
|
2020
Q2 | $343K | Buy |
+13,500
| New | +$343K | 0.06% | 569 |
|